Could modafinil be an option in the treatment of sexual dysfunctions due to antidepressant use in women? Two Case Reports

Antidepressants are known to cause sexual dysfunctions. Sexual side effects due to antidepressants negatively affect compliance with treatment. Modafinil is a stimulant drug used for narcolepsy and some other sleep disorders. It is also used in treatment of resistant depression, chronic fatigue synd...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Türk psikiyatri dergisi 2022-10, Vol.33 (3), p.206-210
1. Verfasser: Yilbas, Baris
Format: Artikel
Sprache:eng ; tur
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 210
container_issue 3
container_start_page 206
container_title Türk psikiyatri dergisi
container_volume 33
creator Yilbas, Baris
description Antidepressants are known to cause sexual dysfunctions. Sexual side effects due to antidepressants negatively affect compliance with treatment. Modafinil is a stimulant drug used for narcolepsy and some other sleep disorders. It is also used in treatment of resistant depression, chronic fatigue syndrome, attention deficit hyperactivity disorder, and cocaine addiction syndrome. In this article, two female patients whose depressive complaints improved with antidepressant treatment, but who applied to the psychiatry outpatient clinic with complaints of sexual dysfunction and daytime sleepiness, will be presented. Both patients had loss of sexual desire, arousal and orgasm difficulties. The sexual histories obtained from the patients suggested that there was no sexual dysfunction in the period before they started using antidepressants. Both patients stated that they did not want to change the current antidepressant treatment. Modafinil 100 mg/day was prescribed to the patients for daytime sleepiness. One month after the initiation of modafinil 100 mg/day in the 39-yearold patient, there was a marked decrease in the complaints of loss of sexual desire, decreased sexual arousal and orgasm difficulties. In the other patient, 43 years old, a slight improvement in sexual functions was observed after the initiation of modafinil. In this case, after the modafinil dose was increased to 200 mg/day, there was a significant improvement in sexual dysfunctions. In both cases, the improvement in sexual dysfunctions and possible mechanisms as a result of the addition of modafinil to the treatment will be discussed.
doi_str_mv 10.5080/u25974
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2717696363</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2929376701</sourcerecordid><originalsourceid>FETCH-LOGICAL-c316t-f0cbc57878b63005d547b9322618dacaac6cc256e61faa7577753b26cea3a0733</originalsourceid><addsrcrecordid>eNpdkVtLxDAQhYMouK76GwKC-FLNZZO0TyLFGywIsj6XNJ1il25Sc0H335uyPvk0w_CdwxwOQpeU3ApSkrvERKVWR2jBpKAFX0l-jBaUE1IwKvkpOgthSwiXJWcLtK9dGju8c53uBzuMuAWsLXZTHJzFg8XxE3D0oOMObMSuxwF-kh5xtw99smbGAu5ShlwWxqGDyUMIecUpwOzw7bL0Hm--Ha51Pr3D5HwM5-ik12OAi7-5RB9Pj5v6pVi_Pb_WD-vCcCpj0RPTGqFKVbYyZxCdWKm24oxJWnbaaG2kMUxIkLTXWgmllOAtkwY010RxvkQ3B9_Ju68EITa7IRgYR23BpdAwRZWsJJczevUP3brkbf6uYRWruJKK0ExdHyjjXQge-mbyw077fUNJMzfQHBrgv_0WeJk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2929376701</pqid></control><display><type>article</type><title>Could modafinil be an option in the treatment of sexual dysfunctions due to antidepressant use in women? Two Case Reports</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Yilbas, Baris</creator><creatorcontrib>Yilbas, Baris</creatorcontrib><description>Antidepressants are known to cause sexual dysfunctions. Sexual side effects due to antidepressants negatively affect compliance with treatment. Modafinil is a stimulant drug used for narcolepsy and some other sleep disorders. It is also used in treatment of resistant depression, chronic fatigue syndrome, attention deficit hyperactivity disorder, and cocaine addiction syndrome. In this article, two female patients whose depressive complaints improved with antidepressant treatment, but who applied to the psychiatry outpatient clinic with complaints of sexual dysfunction and daytime sleepiness, will be presented. Both patients had loss of sexual desire, arousal and orgasm difficulties. The sexual histories obtained from the patients suggested that there was no sexual dysfunction in the period before they started using antidepressants. Both patients stated that they did not want to change the current antidepressant treatment. Modafinil 100 mg/day was prescribed to the patients for daytime sleepiness. One month after the initiation of modafinil 100 mg/day in the 39-yearold patient, there was a marked decrease in the complaints of loss of sexual desire, decreased sexual arousal and orgasm difficulties. In the other patient, 43 years old, a slight improvement in sexual functions was observed after the initiation of modafinil. In this case, after the modafinil dose was increased to 200 mg/day, there was a significant improvement in sexual dysfunctions. In both cases, the improvement in sexual dysfunctions and possible mechanisms as a result of the addition of modafinil to the treatment will be discussed.</description><identifier>ISSN: 1300-2163</identifier><identifier>EISSN: 2651-3463</identifier><identifier>DOI: 10.5080/u25974</identifier><language>eng ; tur</language><publisher>Ankara: Turkiye Sinir ve Ruh Sagligi Dernegi (Turkish Association of Nervous and Mental Health)</publisher><subject>Antidepressants ; Chronic fatigue syndrome ; Orgasm ; Patients ; Sexual disorders</subject><ispartof>Türk psikiyatri dergisi, 2022-10, Vol.33 (3), p.206-210</ispartof><rights>Copyright Turkiye Sinir ve Ruh Sagligi Dernegi (Turkish Association of Nervous and Mental Health) 2022</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c316t-f0cbc57878b63005d547b9322618dacaac6cc256e61faa7577753b26cea3a0733</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Yilbas, Baris</creatorcontrib><title>Could modafinil be an option in the treatment of sexual dysfunctions due to antidepressant use in women? Two Case Reports</title><title>Türk psikiyatri dergisi</title><description>Antidepressants are known to cause sexual dysfunctions. Sexual side effects due to antidepressants negatively affect compliance with treatment. Modafinil is a stimulant drug used for narcolepsy and some other sleep disorders. It is also used in treatment of resistant depression, chronic fatigue syndrome, attention deficit hyperactivity disorder, and cocaine addiction syndrome. In this article, two female patients whose depressive complaints improved with antidepressant treatment, but who applied to the psychiatry outpatient clinic with complaints of sexual dysfunction and daytime sleepiness, will be presented. Both patients had loss of sexual desire, arousal and orgasm difficulties. The sexual histories obtained from the patients suggested that there was no sexual dysfunction in the period before they started using antidepressants. Both patients stated that they did not want to change the current antidepressant treatment. Modafinil 100 mg/day was prescribed to the patients for daytime sleepiness. One month after the initiation of modafinil 100 mg/day in the 39-yearold patient, there was a marked decrease in the complaints of loss of sexual desire, decreased sexual arousal and orgasm difficulties. In the other patient, 43 years old, a slight improvement in sexual functions was observed after the initiation of modafinil. In this case, after the modafinil dose was increased to 200 mg/day, there was a significant improvement in sexual dysfunctions. In both cases, the improvement in sexual dysfunctions and possible mechanisms as a result of the addition of modafinil to the treatment will be discussed.</description><subject>Antidepressants</subject><subject>Chronic fatigue syndrome</subject><subject>Orgasm</subject><subject>Patients</subject><subject>Sexual disorders</subject><issn>1300-2163</issn><issn>2651-3463</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkVtLxDAQhYMouK76GwKC-FLNZZO0TyLFGywIsj6XNJ1il25Sc0H335uyPvk0w_CdwxwOQpeU3ApSkrvERKVWR2jBpKAFX0l-jBaUE1IwKvkpOgthSwiXJWcLtK9dGju8c53uBzuMuAWsLXZTHJzFg8XxE3D0oOMObMSuxwF-kh5xtw99smbGAu5ShlwWxqGDyUMIecUpwOzw7bL0Hm--Ha51Pr3D5HwM5-ik12OAi7-5RB9Pj5v6pVi_Pb_WD-vCcCpj0RPTGqFKVbYyZxCdWKm24oxJWnbaaG2kMUxIkLTXWgmllOAtkwY010RxvkQ3B9_Ju68EITa7IRgYR23BpdAwRZWsJJczevUP3brkbf6uYRWruJKK0ExdHyjjXQge-mbyw077fUNJMzfQHBrgv_0WeJk</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Yilbas, Baris</creator><general>Turkiye Sinir ve Ruh Sagligi Dernegi (Turkish Association of Nervous and Mental Health)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>EDSIH</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>7X8</scope></search><sort><creationdate>20221001</creationdate><title>Could modafinil be an option in the treatment of sexual dysfunctions due to antidepressant use in women? Two Case Reports</title><author>Yilbas, Baris</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c316t-f0cbc57878b63005d547b9322618dacaac6cc256e61faa7577753b26cea3a0733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; tur</language><creationdate>2022</creationdate><topic>Antidepressants</topic><topic>Chronic fatigue syndrome</topic><topic>Orgasm</topic><topic>Patients</topic><topic>Sexual disorders</topic><toplevel>online_resources</toplevel><creatorcontrib>Yilbas, Baris</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Turkey Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><jtitle>Türk psikiyatri dergisi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yilbas, Baris</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Could modafinil be an option in the treatment of sexual dysfunctions due to antidepressant use in women? Two Case Reports</atitle><jtitle>Türk psikiyatri dergisi</jtitle><date>2022-10-01</date><risdate>2022</risdate><volume>33</volume><issue>3</issue><spage>206</spage><epage>210</epage><pages>206-210</pages><issn>1300-2163</issn><eissn>2651-3463</eissn><abstract>Antidepressants are known to cause sexual dysfunctions. Sexual side effects due to antidepressants negatively affect compliance with treatment. Modafinil is a stimulant drug used for narcolepsy and some other sleep disorders. It is also used in treatment of resistant depression, chronic fatigue syndrome, attention deficit hyperactivity disorder, and cocaine addiction syndrome. In this article, two female patients whose depressive complaints improved with antidepressant treatment, but who applied to the psychiatry outpatient clinic with complaints of sexual dysfunction and daytime sleepiness, will be presented. Both patients had loss of sexual desire, arousal and orgasm difficulties. The sexual histories obtained from the patients suggested that there was no sexual dysfunction in the period before they started using antidepressants. Both patients stated that they did not want to change the current antidepressant treatment. Modafinil 100 mg/day was prescribed to the patients for daytime sleepiness. One month after the initiation of modafinil 100 mg/day in the 39-yearold patient, there was a marked decrease in the complaints of loss of sexual desire, decreased sexual arousal and orgasm difficulties. In the other patient, 43 years old, a slight improvement in sexual functions was observed after the initiation of modafinil. In this case, after the modafinil dose was increased to 200 mg/day, there was a significant improvement in sexual dysfunctions. In both cases, the improvement in sexual dysfunctions and possible mechanisms as a result of the addition of modafinil to the treatment will be discussed.</abstract><cop>Ankara</cop><pub>Turkiye Sinir ve Ruh Sagligi Dernegi (Turkish Association of Nervous and Mental Health)</pub><doi>10.5080/u25974</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1300-2163
ispartof Türk psikiyatri dergisi, 2022-10, Vol.33 (3), p.206-210
issn 1300-2163
2651-3463
language eng ; tur
recordid cdi_proquest_miscellaneous_2717696363
source EZB-FREE-00999 freely available EZB journals
subjects Antidepressants
Chronic fatigue syndrome
Orgasm
Patients
Sexual disorders
title Could modafinil be an option in the treatment of sexual dysfunctions due to antidepressant use in women? Two Case Reports
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T02%3A17%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Could%20modafinil%20be%20an%20option%20in%20the%20treatment%20of%20sexual%20dysfunctions%20due%20to%20antidepressant%20use%20in%20women?%20Two%20Case%20Reports&rft.jtitle=T%C3%BCrk%20psikiyatri%20dergisi&rft.au=Yilbas,%20Baris&rft.date=2022-10-01&rft.volume=33&rft.issue=3&rft.spage=206&rft.epage=210&rft.pages=206-210&rft.issn=1300-2163&rft.eissn=2651-3463&rft_id=info:doi/10.5080/u25974&rft_dat=%3Cproquest_cross%3E2929376701%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2929376701&rft_id=info:pmid/&rfr_iscdi=true